Efficacy and safety of surgical treatment for 1–2 cm sized lower pole of renal stone: network meta-analysis of randomized control trials
Urolithiasis · 15.05.2023 · 51 (1)
DOI: 10.1007/s00240-023-01454-2 ↗Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift Urolithiasis, online erschienen am 15.05.2023. Verfasst von Atalel Fentahun Awedew und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Addis Ababa University, Addis Ababa, Ethiopia. atalel.fentahun@aau.edu.et. Hauptthemen laut MEDLINE: Lithotripsy, Kidney Calculi, Nephrolithotomy, Percutaneous. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
The management of medium-sized (1-2 cm) lower poles renal stone has been a contentious topic for endourologists. There are limited evidences to answer the best management options for medium-sized lower pole renal stone. This network meta-analysis provided high-level evidences on efficacy and safety of profile of PCNL, Mini-PCNL, Ultra-PCNL, RIRS, Micro-PCNL, SWL for management of medium-sized lower pole renal stone. Systemic review and network meta-analysis (NMA) of randomized control trials was conducted. The PICOS (Population, Interventions, Comparison, Outcomes, and Study) approach was used to look for relevant studies. Searches were conducted at major electronic databases like Medline via PubMed, Embase, Google Scholar, SCOPUS, ScienceDirect, Cochrane library, Web of Science, and ClinicalTrials.gov to find relevant articles from the inception to April 19, 2023. Fourteen randomized control trials involving 2194 patients were among these studies that met the eligibility criteria. Pooled SFR was Mini-PNCL 98% (95% CI 96-99%), Ultara-PCNL 96% (95% CI 93-98%), RIRS 90% (95% CI 88-92%), PCNL 88% (95% CI 85-92%), Micro-PCNL 77% (61-88%) and SWL 69% (95% CI 65-74%). Mini-PCNL provided a statistically significant higher SFR compared to RIRS (RR = 2.43 91.52; 3.89)), Micro-PCNL (RR = 3.19 (1.09; 9.38)), and SWL (RR = 6.17 (3.65; 10.44)), but there was no statistical significance with standard PCNL (RR = 1.06 (0.52; 2.16)) and Ultra-PCNL (RR = 1.37 (0.75; 2.51)) for management of medium-sized lower pole renal stone. The order of SUCRA values for complication rate was as follows: PCNL(90%), Micro-PCNL(70%), Mini-PCNL(50%), Ultra-PCNL(50%), RIRS(40%), and SWL(10%). The current pooled evidence from fourteen randomized control trials revealed that Mini-PCNL, Ultra-PCNL, and standard PCNL are likely the best treatments for medium-sized lower poles when SFR over a short period of minimal session is a priority. These treatment options have a higher rate of complications, longer hospital stays, and acceptable operations time. RIRS and SWL treatment have acceptable efficacy stone-free rate with low complication rate, short hospital stays, and operation time. These treatment option would be the best fit for solitary kidney, coagulopathy, and comorbidity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Addis Ababa University, Addis Ababa, Ethiopia. atalel.fentahun@aau.edu.et.
- Department of Surgery, Addis Ababa University, Addis Ababa, Ethiopia.
Zitieren
APA
Awedew, A. F., Seman, Y. S., Yalew, D. Z., Wondmeneh, Y. C., & Yigzaw, W. A. (2023). Efficacy and safety of surgical treatment for 1–2 cm sized lower pole of renal stone: network meta-analysis of randomized control trials. Urolithiasis, 51(1). https://doi.org/10.1007/s00240-023-01454-2
Vancouver
Awedew AF, Seman YS, Yalew DZ, Wondmeneh YC, Yigzaw WA. Efficacy and safety of surgical treatment for 1–2 cm sized lower pole of renal stone: network meta-analysis of randomized control trials. Urolithiasis. 2023;51(1). doi:10.1007/s00240-023-01454-2
BibTeX
@article{Awedew2023,
author = {Awedew, Atalel Fentahun and Seman, Yakob Sheiferawe and Yalew, Dawit Zerihun and Wondmeneh, Yohannes Chemere and Yigzaw, Wassie Almaw},
title = {Efficacy and safety of surgical treatment for 1–2 cm sized lower pole of renal stone: network meta-analysis of randomized control trials},
journal = {Urolithiasis},
year = {2023},
volume = {51},
number = {1},
doi = {10.1007/s00240-023-01454-2}
}
EUVIMED